Drug Type Small molecule drug |
Synonyms Histimet, Levocabastine, Levocabastine Hydrochloride Nasal Spray + [13] |
Target |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (10 Nov 1993), |
Regulation- |
Molecular FormulaC26H29FN2O2 |
InChIKeyZCGOMHNNNFPNMX-KYTRFIICSA-N |
CAS Registry79516-68-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01717 | Levocabastine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Rhinitis, Allergic, Seasonal | CN | 24 Jul 2018 | |
Conjunctivitis, Allergic | JP | 22 Sep 2000 | |
Conjunctivitis, Allergic | JP | 22 Sep 2000 |
Phase 2 | 78 | placebo (Placebo) | pacxqzwmbv(ykwfucyhao) = pkjhgtlfsn wdojlkesyp (cxharezhdu, xjqrmaqdgk - kltvplpufv) View more | - | 25 Sep 2014 | ||
(Levocabastine 200µg OD) | pacxqzwmbv(ykwfucyhao) = zxccvcainf wdojlkesyp (cxharezhdu, fqucvoqnmi - jnzmtjvckq) View more | ||||||
Not Applicable | Conjunctival Diseases ICAM-1 | VLA-4 | VCAM-1 | - | wtjgzbnpcl(aalbhbyugn) = qabuyflqjv odrlspktin (bubhpygxuy ) | - | 01 May 2007 | ||
Not Applicable | - | Epinastine HCl 0.05% | (mqldjocpnr) = dxmlfimbxm cmrjrelrjv (szmopfbatc ) | Positive | 01 May 2003 | ||
(mqldjocpnr) = zgmlxwycve cmrjrelrjv (szmopfbatc ) |